Class I recall issued for Sapien 3 balloon


The Food and Drug Administration has issued a class I correction recall for Edward Lifescience’s Sapien 3 balloon system, which is used to deploy transcatheter aortic valve replacements, according to a release from the agency. A class I recall is the most serious the agency issues and indicates risk of severe injury or even death.

FDA icon Wikimedia Commons/FitzColinGerald/ Creative Commons License

Rather than indicate removal of the device from market, this recall provides details on how to use the device cautiously and safely and instructs physicians on proper technique to safely retract the delivery system into the sheath in cases of a suspected balloon burst. Failure to observe these recommendations can result in vascular injury, bleeding, or surgical intervention.

These recommendations and instructions reiterate those issued in an Urgent Field Safety Notice that was provided by Edward Lifesciences on July 9, 2019. Edward Lifesciences could not be reached for comment.

Recommended Reading

Two trials support shorter DAPT without aspirin after stent
MDedge Cardiology
Does endovascular thrombectomy benefit stroke patients with large infarcts?
MDedge Cardiology
Abbott issues recall on Ellipse ICDs
MDedge Cardiology
TAVR valves now FDA approved for low-risk patients
MDedge Cardiology
Post-TAVR anticoagulation alone fails to cut stroke risk in AFib
MDedge Cardiology